Human	B-cell_type
normal	I-cell_type
peripheral	I-cell_type
blood	I-cell_type
B-lymphocytes	I-cell_type
are	O
deficient	O
in	O
DNA-dependent	O
protein	O
kinase	O
activity	O
due	O
to	O
the	O
expression	O
of	O
a	O
variant	O
form	O
of	O
the	O
Ku86	B-protein
protein	I-protein
.	O

The	O
heterodimeric	O
Ku	B-protein
protein	I-protein
,	O
which	O
comprises	O
a	O
86	B-protein
kDa	I-protein
(	I-protein
Ku86	I-protein
)	I-protein
amd	O
a	O
70	B-protein
kDa	I-protein
(	I-protein
Ku70	I-protein
)	I-protein
subunits	I-protein
,	O
is	O
an	O
abundant	O
nuclear	B-protein
DNA-binding	I-protein
protein	I-protein
which	O
binds	O
in	O
vitro	O
to	O
DNA	B-DNA
termini	I-DNA
without	O
sequence	O
specificity	O
.	O

Ku	B-protein
is	O
the	O
DNA-targeting	B-protein
component	I-protein
of	O
the	O
large	O
catalytic	B-protein
sub-unit	I-protein
of	O
the	O
DNA-dependent	B-protein
protein	I-protein
kinase	I-protein
complex	I-protein
(	O
DNA-PK	B-protein
[	I-protein
CS	I-protein
]	I-protein
)	O
,	O
that	O
plays	O
a	O
critical	O
role	O
in	O
mammalian	O
double-strand	O
break	O
repair	O
and	O
lymphoid	O
V	O
(	O
D	O
)	O
J	O
recombination	O
.	O

By	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
demonstrated	O
that	O
in	O
addition	O
to	O
the	O
major	B-protein
Ku	I-protein
x	I-protein
DNA	I-protein
complex	I-protein
usually	O
detected	O
in	O
cell	O
line	O
extracts	O
,	O
a	O
second	O
complex	O
with	O
faster	O
electrophoretic	O
mobility	O
was	O
observed	O
in	O
normal	O
peripheral	B-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
(	O
PBL	B-cell_type
)	O
extracts	O
.	O

The	O
presence	O
of	O
this	O
faster	B-protein
migrating	I-protein
complex	I-protein
was	O
restricted	O
to	O
B	B-cell_type
cells	I-cell_type
among	O
the	O
circulating	B-cell_type
lymphocyte	I-cell_type
population	I-cell_type
.	O

Western	O
blot	O
analysis	O
revealed	O
that	O
B	B-cell_type
cells	I-cell_type
express	O
a	O
variant	O
form	O
of	O
the	O
Ku86	B-protein
protein	I-protein
with	O
an	O
apparent	O
molecular	O
weight	O
of	O
69	O
kDa	O
,	O
and	O
not	O
the	O
86	B-protein
kDa-	I-protein
full-length	I-protein
protein	I-protein
.	O

Although	O
the	O
heterodimer	B-protein
Ku70/variant-Ku86	I-protein
binds	O
to	O
DNA-ends	B-DNA
,	O
this	O
altered	O
form	O
of	O
the	O
Ku	B-protein
heterodimer	I-protein
has	O
a	O
decreased	O
ability	O
to	O
recruit	O
the	O
catalytic	B-protein
component	I-protein
of	O
the	O
complex	O
,	O
DNA-PK	B-protein
(	I-protein
CS	I-protein
)	I-protein
,	O
which	O
contributes	O
to	O
an	O
absence	O
of	O
detectable	O
DNA-PK	O
activity	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

These	O
data	O
provide	O
a	O
molecular	O
basis	O
for	O
the	O
increased	O
sensitivity	O
of	O
B	B-cell_type
cells	I-cell_type
to	O
ionizing	O
radiation	O
and	O
identify	O
a	O
new	O
mechanism	O
of	O
regulation	O
of	O
DNA-PK	O
activity	O
that	O
operates	O
in	O
vivo	O
.	O

Oncogene	NULL
(	NULL
1998	NULL
)	NULL
16	NULL
,	NULL
1553-1560	NULL
©	NULL
1998	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/98	NULL
$	NULL
12.00	NULL
Human	NULL
normal	NULL
peripheral	NULL
blood	NULL
B-lymphocytes	NULL
are	NULL
deficient	NULL
in	NULL
DNA-dependent	NULL
protein	NULL
kinase	NULL
activity	NULL
due	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
Catherine	NULL
Muller	NULL
,	NULL
Caroline	NULL
Dusseau	NULL
,	NULL
Patrick	NULL
Calsou	NULL
and	NULL
Bernard	NULL
Salles	NULL
Institut	NULL
de	NULL
Pharmacologie	NULL
et	NULL
de	NULL
Biologie	NULL
Structurale	NULL
(	NULL
CNRS	NULL
,	NULL
UPR	NULL
9062	NULL
)	NULL
205	NULL
route	NULL
de	NULL
Narbonne	NULL
,	NULL
31077	NULL
Toulouse	NULL
cedex	NULL
,	NULL
France	NULL
The	NULL
heterodimeric	NULL
Ku	NULL
protein	NULL
,	NULL
which	NULL
comprises	NULL
a	NULL
86	NULL
kDa	NULL
(	NULL
Ku86	NULL
)	NULL
amd	NULL
a	NULL
70	NULL
kDa	NULL
(	NULL
Ku70	NULL
)	NULL
subunits	NULL
,	NULL
is	NULL
an	NULL
abundant	NULL
nuclear	NULL
DNA-binding	NULL
protein	NULL
which	NULL
binds	NULL
in	NULL
vitro	NULL
to	NULL
DNA	NULL
termini	NULL
without	NULL
sequence	NULL
specificity	NULL
.	NULL

Ku	NULL
is	NULL
the	NULL
DNA-targeting	NULL
component	NULL
of	NULL
the	NULL
large	NULL
catalytic	NULL
sub-unit	NULL
of	NULL
the	NULL
DNA-dependent	NULL
protein	NULL
kinase	NULL
complex	NULL
(	NULL
DNA-PK	NULL
,	NULL
;	NULL
)	NULL
,	NULL
that	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
mammalian	NULL
double-strand	NULL
break	NULL
repair	NULL
and	NULL
lymphoid	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
.	NULL

By	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
major	NULL
Ku	NULL
DNA	NULL
complex	NULL
usually	NULL
detected	NULL
in	NULL
cell	NULL
line	NULL
extracts	NULL
,	NULL
a	NULL
second	NULL
complex	NULL
with	NULL
faster	NULL
electrophoretic	NULL
mobility	NULL
was	NULL
observed	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
extracts	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
this	NULL
faster	NULL
migrating	NULL
complex	NULL
was	NULL
restricted	NULL
to	NULL
B	NULL
cells	NULL
among	NULL
the	NULL
circulating	NULL
lymphocyte	NULL
population	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
revealed	NULL
that	NULL
B	NULL
cells	NULL
express	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
69	NULL
kDa	NULL
,	NULL
and	NULL
not	NULL
the	NULL
86	NULL
kDa-	NULL
full-length	NULL
protein	NULL
.	NULL

Although	NULL
the	NULL
heterodimer	NULL
Ku70/variant-Ku86	NULL
binds	NULL
to	NULL
DNA-ends	NULL
,	NULL
this	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
has	NULL
a	NULL
decreased	NULL
ability	NULL
to	NULL
recruit	NULL
the	NULL
catalytic	NULL
component	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
DNA-PKcs	NULL
,	NULL
which	NULL
contributes	NULL
to	NULL
an	NULL
absence	NULL
of	NULL
detectable	NULL
DNA-PK	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
These	NULL
data	NULL
provide	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
increased	NULL
sensitivity	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
ionizing	NULL
radiation	NULL
and	NULL
identify	NULL
a	NULL
new	NULL
mechanism	NULL
of	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
that	NULL
operates	NULL
in	NULL
vivo	NULL
.	NULL

Keywords	NULL
:	NULL
DNA-PK	NULL
;	NULL
Ku	NULL
autoantigen	NULL
;	NULL
B-lymphocytes	NULL
;	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
Introduction	NULL
Ku	NULL
protein	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
an	NULL
autoantigen	NULL
recognized	NULL
by	NULL
sera	NULL
from	NULL
patients	NULL
with	NULL
autoimmune	NULL
diseases	NULL
(	NULL
Minori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
)	NULL
.	NULL

Ku	NULL
antigen	NULL
was	NULL
purified	NULL
by	NULL
immunoaffinity	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
heterodimer	NULL
consisting	NULL
of	NULL
86	NULL
kDa	NULL
(	NULL
Ku86	NULL
)	NULL
and	NULL
70	NULL
kDa	NULL
(	NULL
Ku70	NULL
)	NULL
subunits	NULL
(	NULL
Francoeur	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Minori	NULL
and	NULL
Hardin	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Biochemical	NULL
analyses	NULL
of	NULL
Ku	NULL
demonstrated	NULL
that	NULL
it	NULL
bound	NULL
in	NULL
vitro	NULL
to	NULL
DNA	NULL
termini	NULL
or	NULL
other	NULL
discontinuities	NULL
in	NULL
the	NULL
DNA	NULL
structure	NULL
without	NULL
apparent	NULL
sequence	NULL
specificity	NULL
(	NULL
Minori	NULL
and	NULL
Hardin	NULL
,	NULL
1986	NULL
;	NULL
Blier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Falzon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Ku	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
possess	NULL
DNA-dependent	NULL
ATPase	NULL
(	NULL
Cao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
Correspondence	NULL
:	NULL
B	NULL
Salles	NULL
Received	NULL
27	NULL
August	NULL
1997	NULL
;	NULL
revised	NULL
24	NULL
October	NULL
1997	NULL
;	NULL
accepted	NULL
24	NULL
October	NULL
1997	NULL
helicase	NULL
(	NULL
Tuteja	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
activities	NULL
.	NULL

Lastly	NULL
,	NULL
Ku	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
sequence-specific	NULL
binding	NULL
within	NULL
the	NULL
promoter	NULL
elements	NULL
of	NULL
genes	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
biochemical	NULL
properties	NULL
have	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
Ku	NULL
in	NULL
DNA	NULL
metabolic	NULL
processes	NULL
such	NULL
as	NULL
recombination	NULL
,	NULL
repair	NULL
,	NULL
replication	NULL
and/or	NULL
transcription	NULL
.	NULL

It	NULL
is	NULL
now	NULL
established	NULL
that	NULL
Ku	NULL
is	NULL
the	NULL
DNA-targetting	NULL
component	NULL
of	NULL
the	NULL
DNA-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
DNA-PK	NULL
)	NULL
complex	NULL
.	NULL

DNA-PK	NULL
consists	NULL
of	NULL
the	NULL
heterodimeric	NULL
Ku	NULL
protein	NULL
and	NULL
a	NULL
large	NULL
catalytic	NULL
subunit	NULL
(	NULL
DNA	NULL
PKs	NULL
)	NULL
,	NULL
a	NULL
460	NULL
kDa	NULL
serine/threonine	NULL
kinase	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
phosphatidyl	NULL
(	NULL
PT	NULL
)	NULL
-3	NULL
kinase	NULL
(	NULL
p110	NULL
)	NULL
family	NULL
(	NULL
Hartley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

DNA-PKcs	NULL
is	NULL
recruited	NULL
to	NULL
DNA	NULL
by	NULL
Ku	NULL
binding	NULL
(	NULL
Gottlieb	NULL
and	NULL
Jackson	NULL
,	NULL
1993	NULL
)	NULL
and	NULL
then	NULL
acquires	NULL
the	NULL
capacity	NULL
,	NULL
at	NULL
least	NULL
in	NULL
vitro	NULL
,	NULL
to	NULL
phosphorylate	NULL
many	NULL
DNA-bound	NULL
proteins	NULL
in	NULL
the	NULL
vicinity	NULL
(	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
series	NULL
of	NULL
mutational	NULL
and	NULL
biochemical	NULL
experiments	NULL
have	NULL
identified	NULL
DNA-PK	NULL
as	NULL
a	NULL
crucial	NULL
component	NULL
of	NULL
the	NULL
mammalian	NULL
double-strand	NULL
breaks	NULL
(	NULL
DSBs	NULL
)	NULL
repair	NULL
apparatus	NULL
.	NULL

Indeed	NULL
,	NULL
cell	NULL
mutants	NULL
with	NULL
a	NULL
defective	NULL
Ku86	NULL
(	NULL
CHO	NULL
xrs	NULL
cells	NULL
)	NULL
are	NULL
sensitive	NULL
to	NULL
ionizing	NULL
radiation	NULL
(	NULL
IR®	NULL
)	NULL
due	NULL
to	NULL
a	NULL
decreased	NULL
ability	NULL
to	NULL
repair	NULL
DSBs	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Jeggo	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
xrs	NULL
cells	NULL
,	NULL
a	NULL
direct	NULL
consequence	NULL
of	NULL
the	NULL
Ku	NULL
defect	NULL
is	NULL
a	NULL
concomitant	NULL
deficiency	NULL
in	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
DNA-PK	NULL
(	NULL
Finnie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
indicating	NULL
that	NULL
Ku	NULL
DNA-binding	NULL
represents	NULL
the	NULL
predominant	NULL
,	NULL
if	NULL
only	NULL
,	NULL
mechanism	NULL
for	NULL
DNA-PK	NULL
activation	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
the	NULL
rodent	NULL
scid	NULL
and	NULL
V-3	NULL
mutants	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
DNA-PK	NULL
,	NULL
,	NULL
(	NULL
Blunt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Peterson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Blunt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Danska	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
confers	NULL
IR®°	NULL
and	NULL
a	NULL
deficiency	NULL
in	NULL
DNA	NULL
DSBs	NULL
repair	NULL
(	NULL
Biederman	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Hendrickson	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IR®	NULL
,	NULL
the	NULL
observed	NULL
defect	NULL
in	NULL
DNA	NULL
DSB	NULL
repair	NULL
alters	NULL
efficient	NULL
joining	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
intermediates	NULL
that	NULL
result	NULL
in	NULL
a	NULL
profound	NULL
immunodeficiency	NULL
.	NULL

The	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
is	NULL
a	NULL
lymphoid	NULL
and	NULL
site-specific	NULL
DNA	NULL
recombination	NULL
process	NULL
that	NULL
assembles	NULL
the	NULL
non	NULL
contiguous	NULL
genomic	NULL
segments	NULL
that	NULL
encode	NULL
the	NULL
Variable	NULL
(	NULL
V	NULL
)	NULL
,	NULL
Diversity	NULL
(	NULL
D	NULL
)	NULL
,	NULL
and	NULL
Joining	NULL
(	NULL
J	NULL
)	NULL
elements	NULL
of	NULL
immunoglo-bulin	NULL
and	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
Weaver	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
mice	NULL
homozygous	NULL
for	NULL
the	NULL
murine	NULL
severe	NULL
combined	NULL
immune	NULL
deficiency	NULL
(	NULL
seid	NULL
)	NULL
mutation	NULL
lack	NULL
mature	NULL
T-	NULL
and	NULL
B-lymphocytes	NULL
,	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
coding	NULL
junction	NULL
-	NULL
formation	NULL
(	NULL
Schuller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Lastly	NULL
,	NULL
knock-out	NULL
mice	NULL
for	NULL
Ku86	NULL
have	NULL
been	NULL
generated	NULL
and	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
these	NULL
mice	NULL
have	NULL
a	NULL
profound	NULL
immunodeficiency	NULL
(	NULL
Zhu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Although	NULL
its	NULL
precise	NULL
role	NULL
remains	NULL
largely	NULL
unknown	NULL
,	NULL
these	NULL
results	NULL
clearly	NULL
identified	NULL
DNA-PK	NULL
as	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
mammalian	NULL
DNA	NULL
repair	NULL
apparatus	NULL
that	NULL
rejoin	NULL
damage-induced	NULL
,	NULL
as	NULL
well	NULL
as	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
intermediates	NULL
,	NULL
DSBs	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
1554	NULL
In	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
Ku	NULL
represents	NULL
the	NULL
major	NULL
double-strand	NULL
DNA	NULL
end	NULL
binding	NULL
protein	NULL
as	NULL
detected	NULL
by	NULL
band	NULL
shift	NULL
experiments	NULL
and	NULL
its	NULL
expression	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
regulated	NULL
within	NULL
cell	NULL
types	NULL
(	NULL
Finnie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
and	NULL
our	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
human	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
no	NULL
changes	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
Ku	NULL
polypeptides	NULL
have	NULL
been	NULL
detected	NULL
following	NULL
treatment	NULL
with	NULL
ionizing	NULL
radiation	NULL
(	NULL
Jongmans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

All	NULL
these	NULL
results	NULL
lead	NULL
to	NULL
the	NULL
idea	NULL
that	NULL
Ku	NULL
activity	NULL
is	NULL
present	NULL
at	NULL
high	NULL
constitutive	NULL
levels	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Despite	NULL
many	NULL
studies	NULL
performed	NULL
with	NULL
established	NULL
cell	NULL
lines	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
Ku	NULL
activity	NULL
in	NULL
normal	NULL
fresh	NULL
human	NULL
cells	NULL
and	NULL
tissues	NULL
.	NULL

Indeed	NULL
,	NULL
only	NULL
a	NULL
few	NULL
studies	NULL
of	NULL
Ku	NULL
gene	NULL
expression	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
date	NULL
(	NULL
Yaneva	NULL
and	NULL
Jhiang	NULL
,	NULL
1991	NULL
;	NULL
Cai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Regarding	NULL
the	NULL
major	NULL
role	NULL
of	NULL
the	NULL
Ku	NULL
protein	NULL
in	NULL
DSBs	NULL
repair	NULL
,	NULL
this	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
important	NULL
question	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
explore	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
have	NULL
chosen	NULL
to	NULL
study	NULL
Ku	NULL
function	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
that	NULL
DNA-PK	NULL
activity	NULL
is	NULL
regulated	NULL
in	NULL
vivo	NULL
,	NULL
through	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
in	NULL
human	NULL
normal	NULL
B	NULL
cells	NULL
.	NULL

Results	NULL
Detection	NULL
of	NULL
an	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterdomer	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
In	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
Ku	NULL
DNA-ends	NULL
binding	NULL
(	NULL
DEB	NULL
)	NULL
activity	NULL
can	NULL
be	NULL
easily	NULL
detected	NULL
by	NULL
using	NULL
dsDNA	NULL
fragments	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
(	NULL
Zhang	NULL
and	NULL
Yanera	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
in	NULL
the	NULL
human	NULL
cell	NULL
lines	NULL
AHH1	NULL
and	NULL
Hela	NULL
,	NULL
at	NULL
least	NULL
three	NULL
complexes	NULL
of	NULL
different	NULL
mobility	NULL
were	NULL
observed	NULL
(	NULL
A	NULL
,	NULL
A	NULL
'	NULL
and	NULL
A	NULL
``	NULL
)	NULL
.	NULL

Ku	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
translocate	NULL
internally	NULL
on	NULL
DNA	NULL
allowing	NULL
another	NULL
Ku	NULL
heterodimer	NULL
to	NULL
bind	NULL
to	NULL
free	NULL
DNA	NULL
ends	NULL
(	NULL
deVries	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
complex	NULL
A	NULL
'	NULL
and	NULL
A	NULL
``	NULL
formation	NULL
in	NULL
association	NULL
with	NULL
increased	NULL
protein	NULL
concentration	NULL
is	NULL
likely	NULL
to	NULL
correspond	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
multiple	NULL
Ku	NULL
heterodimers	NULL
to	NULL
the	NULL
same	NULL
DNA-probe	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Zhang	NULL
and	NULL
Yaneva	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

When	NULL
PBL	NULL
extracts	NULL
were	NULL
considered	NULL
,	NULL
the	NULL
results	NULL
consistently	NULL
showed	NULL
two	NULL
features	NULL
independent	NULL
of	NULL
the	NULL
origin	NULL
of	NULL
the	NULL
samples	NULL
tested	NULL
(	NULL
shown	NULL
for	NULL
three	NULL
different	NULL
donors	NULL
in	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Firstly	NULL
,	NULL
DEB	NULL
activity	NULL
appears	NULL
lower	NULL
in	NULL
PBL	NULL
extracts	NULL
than	NULL
the	NULL
one	NULL
observed	NULL
for	NULL
established	NULL
cell	NULL
lines	NULL
.	NULL

Secondly	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
major	NULL
complex	NULL
usually	NULL
detected	NULL
in	NULL
cell	NULL
lines	NULL
(	NULL
complex	NULL
A	NULL
)	NULL
,	NULL
a	NULL
second	NULL
complex	NULL
with	NULL
faster	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
complex	NULL
B	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
PBL	NULL
extracts	NULL
.	NULL

In	NULL
PBL	NULL
,	NULL
the	NULL
signal	NULL
due	NULL
to	NULL
these	NULL
two	NULL
different	NULL
complexes	NULL
appeared	NULL
almost	NULL
identical	NULL
.	NULL

This	NULL
profile	NULL
of	NULL
DEB	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
the	NULL
PBL	NULL
extracts	NULL
tested	NULL
in	NULL
our	NULL
laboratory	NULL
(	NULL
obtained	NULL
to	NULL
date	NULL
from	NULL
six	NULL
different	NULL
healthy	NULL
donors	NULL
)	NULL
.	NULL

In	NULL
our	NULL
hands	NULL
,	NULL
this	NULL
unusual	NULL
pattern	NULL
of	NULL
DEB	NULL
activity	NULL
observed	NULL
in	NULL
PBL	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
transformed	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
or	NULL
rodent	NULL
origin	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
DEB	NULL
activity	NULL
observed	NULL
in	NULL
PBL	NULL
suggests	NULL
either	NULL
that	NULL
an	NULL
additional	NULL
protein	NULL
,	NULL
expressed	NULL
only	NULL
in	NULL
this	NULL
cell	NULL
population	NULL
,	NULL
is	NULL
able	NULL
to	NULL
recognize	NULL
double-stranded	NULL
DNA-ends	NULL
or	NULL
that	NULL
the	NULL
Ku	NULL
heterodimer	NULL
is	NULL
present	NULL
in	NULL
an	NULL
altered	NULL
form	NULL
in	NULL
PBL	NULL
extracts	NULL
.	NULL

To	NULL
test	NULL
these	NULL
two	NULL
Extracts	NULL
2	NULL
ug	NULL
4	NULL
ug	NULL
PBL	NULL
PBL	NULL
A	NULL
H	NULL
1°	NULL
2	NULL
3	NULL
A	NULL
Ho10	NULL
2	NULL
3	NULL
«	NULL
*	NULL
#	NULL
“	NULL
an	NULL
:	NULL
A	NULL
``	NULL
-	NULL
>	NULL
j	NULL
a	NULL
-	NULL
>	NULL
<	NULL
<	NULL
#	NULL
#	NULL
<	NULL
<	NULL
0	NULL
mike	NULL
tig	NULL
t	NULL
n	NULL
A	NULL
-__	NULL
<	NULL
+	NULL
B	NULL
Figure	NULL
1	NULL
A	NULL
second	NULL
protein-DNA	NULL
ends	NULL
complex	NULL
with	NULL
faster	NULL
electrophoretic	NULL
mobility	NULL
is	NULL
detected	NULL
in	NULL
PBL	NULL
extracts	NULL
.	NULL

Increasing	NULL
concentrations	NULL
of	NULL
protein	NULL
extracts	NULL
obtained	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
(	NULL
A	NULL
,	NULL
AHH1	NULL
;	NULL
H	NULL
,	NULL
HeLa	NULL
)	NULL
or	NULL
PBL	NULL
(	NULL
three	NULL
independent	NULL
healthy	NULL
donors	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
0.1	NULL
ng	NULL
°°P-labeled	NULL
DNA	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
closed	NULL
circular	NULL
plasmid	NULL
DNA	NULL
,	NULL
as	NULL
a	NULL
non	NULL
specific	NULL
competitor	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
analysed	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

F	NULL
,	NULL
position	NULL
of	NULL
free	NULL
DNA	NULL
probe	NULL
;	NULL
A	NULL
,	NULL
A	NULL
'	NULL
,	NULL
A	NULL
``	NULL
and	NULL
B	NULL
,	NULL
positions	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
consisting	NULL
of	NULL
DNA-ends	NULL
binding	NULL
activity	NULL
hypotheses	NULL
,	NULL
we	NULL
first	NULL
evaluated	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Ku70	NULL
and	NULL
Ku86	NULL
proteins	NULL
in	NULL
the	NULL
B	NULL
complex	NULL
,	NULL
by	NULL
using	NULL
various	NULL
antibodies	NULL
directed	NULL
against	NULL
these	NULL
proteins	NULL
in	NULL
EMSA	NULL
supershift	NULL
experiments	NULL
.	NULL

First	NULL
,	NULL
the	NULL
autoantibodies	NULL
(	NULL
purified	NULL
from	NULL
the	NULL
AF	NULL
human	NULL
serum	NULL
)	NULL
,	NULL
which	NULL
were	NULL
shown	NULL
to	NULL
recognize	NULL
the	NULL
Ku70	NULL
and	NULL
Ku86	NULL
proteins	NULL
(	NULL
Francoeur	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
,	NULL
were	NULL
used	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
antibodies	NULL
,	NULL
both	NULL
A	NULL
and	NULL
B	NULL
complexes	NULL
were	NULL
completely	NULL
supershifted	NULL
and	NULL
retarded	NULL
in	NULL
the	NULL
gel	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
(	NULL
panel	NULL
I	NULL
)	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
antibodies	NULL
directed	NULL
either	NULL
against	NULL
Ku70	NULL
or	NULL
Ku86	NULL
,	NULL
to	NULL
further	NULL
assess	NULL
the	NULL
presence	NULL
in	NULL
the	NULL
B	NULL
complex	NULL
of	NULL
each	NULL
subunit	NULL
of	NULL
the	NULL
Ku	NULL
herodimer	NULL
.	NULL

For	NULL
Ku86	NULL
,	NULL
two	NULL
different	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
a	NULL
polyclonal	NULL
antibody	NULL
,	NULL
Ku86	NULL
pc	NULL
,	NULL
and	NULL
mAb	NULL
S10B1	NULL
which	NULL
recognizes	NULL
an	NULL
epitope	NULL
defined	NULL
by	NULL
aa	NULL
8-221	NULL
on	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Ku86	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
(	NULL
panel	NULL
II	NULL
and	NULL
III	NULL
)	NULL
,	NULL
all	NULL
Ku	NULL
antibodies	NULL
supershifted	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
complex	NULL
B	NULL
present	NULL
in	NULL
PBL	NULL
extracts	NULL
and	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
complex	NULL
A	NULL
present	NULL
in	NULL
PBL	NULL
and	NULL
AHH1	NULL
extracts	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
mAB	NULL
S10Bl	NULL
affected	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
complex	NULL
B	NULL
less	NULL
than	NULL
the	NULL
other	NULL
Ku	NULL
Abs	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
,	NULL
panel	NULL
III	NULL
)	NULL
.	NULL

However	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
the	NULL
complex	NULL
A	NULL
present	NULL
in	NULL
PBL	NULL
and	NULL
in	NULL
AHHI1	NULL
extracts	NULL
suggesting	NULL
that	NULL
this	NULL
lower	NULL
reactivity	NULL
is	NULL
an	NULL
inherent	NULL
property	NULL
of	NULL
this	NULL
antibody	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
set	NULL
of	NULL
experiments	NULL
showed	NULL
that	NULL
both	NULL
Ku70	NULL
and	NULL
Ku86	NULL
were	NULL
present	NULL
in	NULL
the	NULL
complex	NULL
B	NULL
,	NULL
the	NULL
faster	NULL
migration	NULL
pattern	NULL
indicating	NULL
that	NULL
one	NULL
or	NULL
both	NULL
Ku	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
an	NULL
altered/modified	NULL
form	NULL
in	NULL
PBL	NULL
extracts	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
the	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
is	NULL
associated	NULL
with	NULL
B-lymphocyte	NULL
population	NULL
In	NULL
PBL	NULL
extracts	NULL
,	NULL
both	NULL
forms	NULL
of	NULL
the	NULL
Ku	NULL
DNA	NULL
complexes	NULL
were	NULL
detected	NULL
by	NULL
EMSA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
might	NULL
be	NULL
AHH1	NULL
PBL	NULL
AF	NULL
Abs	NULL
(	NULL
ug	NULL
)	NULL
C	NULL
0.1	NULL
0.2	NULL
0.3C	NULL
0.1	NULL
0.2	NULL
0.3	NULL
Supershift	NULL
(	NULL
ted	NULL
'-	NULL
-	NULL
We	NULL
_	NULL
>	NULL
Ku	NULL
80/Ku	NULL
70	NULL
|	NULL
C	NULL
pc	NULL
C	NULL
===	NULL
[	NULL
|	NULL
Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
1555	NULL
AHH1	NULL
PBL	NULL
AHH1	NULL
PBL	NULL
C	NULL
pc	NULL
C	NULL
pc	NULL
S10B1	NULL
C	NULL
pc	NULL
S10B1	NULL
w*	NULL
in	NULL
jai	NULL
®	NULL
#	NULL
0	NULL
CV	NULL
``	NULL
wo	NULL
-	NULL
HoW	NULL
DoW	NULL
&	NULL
#	NULL
#	NULL
i	NULL
ting	NULL
-	NULL
»	NULL
Ku	NULL
70	NULL
Ku	NULL
86	NULL
II	NULL
III	NULL
Figure	NULL
2	NULL
EMSA	NULL
supershift	NULL
experiments	NULL
demonstrate	NULL
that	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
contained	NULL
both	NULL
Ku70	NULL
and	NULL
Ku86	NULL
proteins	NULL
.	NULL

4	NULL
ug	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
0.1	NULL
ng	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
closed	NULL
circular	NULL
plasmid	NULL
DNA	NULL
,	NULL
as	NULL
a	NULL
non	NULL
specific	NULL
competitor	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
either	NULL
no	NULL
antibody	NULL
(	NULL
control	NULL
)	NULL
or	NULL
antibodies	NULL
specific	NULL
for	NULL
(	NULL
I	NULL
)	NULL
Ku70	NULL
and	NULL
Ku86	NULL
proteins	NULL
(	NULL
mAbs	NULL
AF	NULL
)	NULL
,	NULL
(	NULL
II	NULL
)	NULL
Ku70	NULL
protein	NULL
(	NULL
Ab	NULL
Ku70	NULL
pc	NULL
)	NULL
,	NULL
(	NULL
III	NULL
)	NULL
Ku86	NULL
protein	NULL
,	NULL
polyclonal	NULL
(	NULL
Ab	NULL
Ku86	NULL
pc	NULL
)	NULL
,	NULL
or	NULL
monoclonal	NULL
that	NULL
recognizes	NULL
aa	NULL
8-221	NULL
(	NULL
mAB	NULL
S10B1	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
prior	NULL
to	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
analysed	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

F	NULL
,	NULL
position	NULL
of	NULL
free	NULL
DNA	NULL
probe	NULL
;	NULL
positions	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
consisting	NULL
of	NULL
DNA-ends	NULL
binding	NULL
activity	NULL
and	NULL
the	NULL
region	NULL
where	NULL
the	NULL
supershifted	NULL
complexes	NULL
migrate	NULL
are	NULL
indicated	NULL
component	NULL
of	NULL
one	NULL
of	NULL
the	NULL
sub-populations	NULL
present	NULL
in	NULL
PBL	NULL
.	NULL

Indeed	NULL
,	NULL
when	NULL
whole	NULL
cell	NULL
extracts	NULL
from	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
evaluated	NULL
,	NULL
only	NULL
the	NULL
faster	NULL
migrating	NULL
B	NULL
complex	NULL
was	NULL
detected	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
B	NULL
cell	NULL
extracts	NULL
,	NULL
the	NULL
mobility	NULL
change	NULL
associated	NULL
with	NULL
increasing	NULL
protein	NULL
concentration	NULL
was	NULL
also	NULL
observed	NULL
(	NULL
detection	NULL
of	NULL
two	NULL
additional	NULL
complexes	NULL
B	NULL
'	NULL
and	NULL
B	NULL
``	NULL
when	NULL
the	NULL
protein	NULL
concentration	NULL
in	NULL
the	NULL
binding	NULL
assay	NULL
is	NULL
4	NULL
ug	NULL
,	NULL
Figure	NULL
3	NULL
)	NULL
suggesting	NULL
that	NULL
the	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
still	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
translocate	NULL
on	NULL
the	NULL
DNA	NULL
as	NULL
previously	NULL
described	NULL
for	NULL
the	NULL
normal	NULL
Ku	NULL
protein	NULL
(	NULL
deVries	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
this	NULL
representative	NULL
experiment	NULL
,	NULL
the	NULL
DEB	NULL
activity	NULL
is	NULL
shown	NULL
in	NULL
proteins	NULL
extracts	NULL
obtained	NULL
from	NULL
the	NULL
whole	NULL
lymphocyte	NULL
population	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
within	NULL
the	NULL
same	NULL
blood	NULL
sample	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
one	NULL
sample	NULL
,	NULL
we	NULL
verified	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
the	NULL
usual	NULL
pattern	NULL
of	NULL
Ku-DEB	NULL
activity	NULL
is	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
is	NULL
largely	NULL
confined	NULL
to	NULL
B	NULL
cells	NULL
among	NULL
the	NULL
circulating	NULL
lymphocyte	NULL
population	NULL
.	NULL

The	NULL
B-lymphocytes	NULL
express	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
To	NULL
further	NULL
characterize	NULL
the	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Ku	NULL
proteins	NULL
was	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
full	NULL
length	NULL
Ku70	NULL
protein	NULL
,	NULL
which	NULL
migrates	NULL
at	NULL
approximately	NULL
72	NULL
kDa	NULL
in	NULL
SDS	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
PBL	NULL
and	NULL
B	NULL
cells	NULL
at	NULL
a	NULL
slightly	NULL
lower	NULL
level	NULL
of	NULL
expression	NULL
(	NULL
about	NULL
twofold	NULL
)	NULL
than	NULL
in	NULL
the	NULL
human	NULL
cell	NULL
lines	NULL
AHH1	NULL
and	NULL
HeLa	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
panel	NULL
I	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Ku86	NULL
protein	NULL
was	NULL
altered	NULL
in	NULL
the	NULL
extracts	NULL
obtained	NULL
from	NULL
lymphocytes	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
panel	NULL
II	NULL
and	NULL
III	NULL
)	NULL
.	NULL

In	NULL
PBL	NULL
extracts	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
full-length	NULL
86	NULL
kDa	NULL
protein	NULL
,	NULL
a	NULL
second	NULL
band	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
anti-Ku86	NULL
pc	NULL
Ab	NULL
appeared	NULL
at	NULL
a	NULL
lower	NULL
position	NULL
corresponding	NULL
to	NULL
about	NULL
69	NULL
kDa	NULL
.	NULL

This	NULL
band	NULL
was	NULL
absent	NULL
in	NULL
extracts	NULL
Extracts	NULL
2	NULL
ug	NULL
4	NULL
ug	NULL
A	NULL
PBL	NULL
__	NULL
LB	NULL
A	NULL
PBL	NULL
_	NULL
LB	NULL
@	NULL
*	NULL
>	NULL
-	NULL
Kh	NULL
i	NULL
Figure	NULL
3	NULL
The	NULL
detection	NULL
of	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
is	NULL
restricted	NULL
to	NULL
B	NULL
cells	NULL
within	NULL
circulating	NULL
lymphocyte	NULL
population	NULL
.	NULL

Increasing	NULL
concentrations	NULL
of	NULL
protein	NULL
extracts	NULL
obtained	NULL
from	NULL
the	NULL
human	NULL
cell	NULL
line	NULL
AHHIl	NULL
(	NULL
A	NULL
)	NULL
,	NULL
PBL	NULL
or	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
0.1	NULL
ng	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
closed	NULL
circular	NULL
plasmid	NULL
DNA	NULL
,	NULL
as	NULL
a	NULL
non	NULL
specific	NULL
competitor	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
analysed	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

F	NULL
,	NULL
position	NULL
of	NULL
free	NULL
DNA	NULL
probe	NULL
;	NULL
the	NULL
positions	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
consisting	NULL
of	NULL
DNA-ends	NULL
binding	NULL
activity	NULL
are	NULL
indicated	NULL
from	NULL
AHH	NULL
!	NULL

and	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
extracts	NULL
,	NULL
the	NULL
full-length	NULL
protein	NULL
was	NULL
not	NULL
detected	NULL
and	NULL
only	NULL
the	NULL
lower	NULL
69	NULL
kDa	NULL
band	NULL
appeared	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
1556	NULL
using	NULL
the	NULL
mAb	NULL
S10Bl	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
full-length	NULL
Ku86	NULL
protein	NULL
was	NULL
undetectable	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
a	NULL
lower	NULL
band	NULL
,	NULL
present	NULL
as	NULL
a	NULL
doublet	NULL
(	NULL
at	NULL
approximately	NULL
69	NULL
and	NULL
71	NULL
kDa	NULL
,	NULL
with	NULL
a	NULL
higher	NULL
expression	NULL
of	NULL
the	NULL
69	NULL
kDa	NULL
protein	NULL
)	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
lymphocytes	NULL
that	NULL
was	NULL
not	NULL
present	NULL
in	NULL
AHHI1	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
panel	NULL
III	NULL
)	NULL
.	NULL

The	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
has	NULL
a	NULL
decreased	NULL
ability	NULL
to	NULL
recruit	NULL
DNA-PKes	NULL
that	NULL
results	NULL
in	NULL
a	NULL
failure	NULL
to	NULL
detect	NULL
DNA-PK	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
The	NULL
Ku	NULL
heterodimer	NULL
is	NULL
the	NULL
DNA-binding	NULL
component	NULL
of	NULL
DNA-PK	NULL
,	NULL
the	NULL
catalytic	NULL
activity	NULL
of	NULL
which	NULL
is	NULL
carried	NULL
by	NULL
a	NULL
460	NULL
kDa	NULL
protein	NULL
,	NULL
DNA-PKcs	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
altered	NULL
Ku	NULL
heterodimer	NULL
retains	NULL
its	NULL
capacity	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
termini	NULL
.	NULL

We	NULL
then	NULL
investigated	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
altered	NULL
heterodimer	NULL
to	NULL
contribute	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ds-DNA	NULL
,	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
DNA-PK	NULL
complex	NULL
.	NULL

First	NULL
,	NULL
the	NULL
protein	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
evaluated	NULL
in	NULL
lymphocytes	NULL
and	NULL
in	NULL
B-purified	NULL
cell	NULL
population	NULL
using	NULL
the	NULL
'pull-down	NULL
'	NULL
assay	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Finnie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
only	NULL
proteins	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
double-stranded	NULL
DNA	NULL
ends	NULL
on	NULL
cellulose	NULL
beads	NULL
are	NULL
considered	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
specificity	NULL
for	NULL
DNA-PK	NULL
activity	NULL
is	NULL
ensured	NULL
through	NULL
the	NULL
use	NULL
of	NULL
both	NULL
a	NULL
consensus	NULL
substrate	NULL
peptide	NULL
issued	NULL
from	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
murine	NULL
p53	NULL
and	NULL
a	NULL
mutated	NULL
peptide	NULL
which	NULL
is	NULL
a	NULL
poor	NULL
substrate	NULL
for	NULL
DNA-PK	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
.	NULL

By	NULL
using	NULL
this	NULL
assay	NULL
,	NULL
a	NULL
detectable	NULL
amount	NULL
of	NULL
DNA-PK	NULL
activity	NULL
was	NULL
found	NULL
in	NULL
PBL	NULL
but	NULL
at	NULL
a	NULL
significantly	NULL
lower	NULL
level	NULL
than	NULL
the	NULL
one	NULL
observed	NULL
in	NULL
the	NULL
AHH1	NULL
and	NULL
HeLa	NULL
human	NULL
cell	NULL
lines	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

In	NULL
B	NULL
cell	NULL
extracts	NULL
,	NULL
no	NULL
detectable	NULL
DNA-PK	NULL
activity	NULL
was	NULL
found	NULL
in	NULL
the	NULL
three	NULL
independent	NULL
samples	NULL
tested	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
can	NULL
be	NULL
deduced	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
the	NULL
DNA-PK	NULL
activity	NULL
detected	NULL
in	NULL
PBL	NULL
was	NULL
solely	NULL
due	NULL
to	NULL
the	NULL
T	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
PBL	NULL
samples	NULL
.	NULL

We	NULL
then	NULL
evaluated	NULL
by	NULL
Western	NULL
blot	NULL
experiments	NULL
the	NULL
expression	NULL
of	NULL
DNA-PK	NULL
,	NULL
in	NULL
these	NULL
different	NULL
samples	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
both	NULL
PBL	NULL
and	NULL
B	NULL
cell	NULL
purified	NULL
population	NULL
extracts	NULL
contained	NULL
DNA-PK	NULL
.	NULL

;	NULL
,	NULL
although	NULL
at	NULL
a	NULL
level	NULL
A	NULL
H	NULL
PBL	NULL
_	NULL
LB	NULL
(	NULL
1	NULL
)	NULL
Ab	NULL
Ku7O0	NULL
pc	NULL
_	NULL
«	NULL
0h	NULL
®	NULL
me	NULL
ly	NULL
'sa	NULL
!	NULL

.	NULL

3	NULL
]	NULL
(	NULL
11	NULL
)	NULL
Ab	NULL
Ku86	NULL
pe	NULL
1	NULL
:	NULL
<	NULL
as	NULL
%	NULL
(	NULL
Ill	NULL
)	NULL
Ab	NULL
S10B1	NULL
-o	NULL
«	NULL
ln	NULL
Figure	NULL
4	NULL
Western	NULL
blot	NULL
analysis	NULL
in	NULL
lymphocyte	NULL
extracts	NULL
revealed	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
.	NULL

50	NULL
ug	NULL
of	NULL
protein	NULL
extracts	NULL
obtained	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
(	NULL
A	NULL
,	NULL
AHH1	NULL
;	NULL
H	NULL
,	NULL
HeLa	NULL
)	NULL
,	NULL
PBL	NULL
or	NULL
B	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
8	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
blotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
Ku	NULL
proteins	NULL
were	NULL
detected	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
with	NULL
indicated	NULL
antibodies	NULL
that	NULL
recognize	NULL
either	NULL
the	NULL
Ku70	NULL
protein	NULL
(	NULL
I	NULL
)	NULL
or	NULL
the	NULL
Ku86	NULL
protein	NULL
(	NULL
II	NULL
and	NULL
III	NULL
)	NULL
which	NULL
appeared	NULL
lower	NULL
(	NULL
about	NULL
twofold	NULL
)	NULL
than	NULL
in	NULL
the	NULL
AHH1	NULL
cell	NULL
line	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
not	NULL
able	NULL
to	NULL
recruit	NULL
the	NULL
catalytic	NULL
sub-unit	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
DNA-PKcs	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
the	NULL
proteins	NULL
associated	NULL
with	NULL
the	NULL
double-stranded	NULL
DNA	NULL
cellulose	NULL
beads	NULL
were	NULL
eluted	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
analyses	NULL
.	NULL

Beads	NULL
which	NULL
have	NULL
been	NULL
incubated	NULL
with	NULL
AHH1	NULL
or	NULL
PBL	NULL
extracts	NULL
contained	NULL
DNA-PKcs	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
beads	NULL
incubated	NULL
with	NULL
B	NULL
cell	NULL
extracts	NULL
lacked	NULL
DNA-PKcs	NULL
.	NULL

Furthermore	NULL
,	NULL
proteins	NULL
associated	NULL
with	NULL
beads	NULL
from	NULL
all	NULL
the	NULL
extracts	NULL
contained	NULL
the	NULL
Ku	NULL
proteins	NULL
.	NULL

Beads	NULL
which	NULL
have	NULL
been	NULL
incubated	NULL
with	NULL
AHH1	NULL
extracts	NULL
contained	NULL
full	NULL
length	NULL
Ku70	NULL
and	NULL
Ku86	NULL
whereas	NULL
beads	NULL
incubated	NULL
with	NULL
B	NULL
cell	NULL
extracts	NULL
contained	NULL
10000	NULL
7	NULL
A	NULL
PBL	NULL
LB	NULL
250	NULL
kDa	NULL
-	NULL
~	NULL
H	NULL
H	NULL
7500	NULL
~	NULL
g	NULL
5000	NULL
2500	NULL
o	NULL
-	NULL
7	NULL
T	NULL
e	NULL
___	NULL
e	NULL
Cell	NULL
lines	NULL
PBL	NULL
B-lymphocytes	NULL
Figure	NULL
5	NULL
B-lymphocytes	NULL
are	NULL
deficient	NULL
in	NULL
DNA-PK	NULL
activity	NULL
.	NULL

Extracts	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
were	NULL
analysed	NULL
by	NULL
the	NULL
DNA-PK	NULL
pull-down	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
wild-type	NULL
(	NULL
black	NULL
squares	NULL
)	NULL
or	NULL
mutated	NULL
(	NULL
hatched	NULL
squares	NULL
)	NULL
p53	NULL
peptide	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
established	NULL
cell	NULL
lines	NULL
corresponded	NULL
to	NULL
AHH1	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

PBL	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
donors	NULL
and	NULL
B	NULL
cell	NULL
extracts	NULL
from	NULL
the	NULL
purified	NULL
B	NULL
population	NULL
of	NULL
these	NULL
three	NULL
same	NULL
samples	NULL
.	NULL

Mean	NULL
of	NULL
at	NULL
least	NULL
two	NULL
experiments	NULL
for	NULL
all	NULL
these	NULL
independent	NULL
extracts	NULL
.	NULL

The	NULL
insert	NULL
shows	NULL
the	NULL
expression	NULL
of	NULL
DNA-PKcs	NULL
in	NULL
these	NULL
different	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
experiments	NULL
using	NULL
mAb	NULL
18-2	NULL
AHH1	NULL
PBL	NULL
LB	NULL
DNA-PK	NULL
cs	NULL
(	NULL
Ab	NULL
18-4	NULL
)	NULL
egg	NULL
-	NULL
=	NULL
Ku70	NULL
(	NULL
Ab	NULL
Ku70	NULL
pc	NULL
)	NULL
K	NULL
86	NULL
(	NULL
Ab	NULL
S10B1	NULL
)	NULL
mse	NULL
Figure	NULL
6	NULL
The	NULL
variant	NULL
Ku	NULL
heterodimer	NULL
is	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
DNA-PKcs	NULL
.	NULL

After	NULL
incubation	NULL
of	NULL
the	NULL
indicated	NULL
protein	NULL
extracts	NULL
with	NULL
ds-DNA	NULL
cellulose	NULL
beads	NULL
,	NULL
the	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
beads	NULL
were	NULL
eluted	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
8	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
reducing	NULL
conditions	NULL
,	NULL
The	NULL
proteins	NULL
were	NULL
then	NULL
blotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
Ku70	NULL
and	NULL
Ku86	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blots	NULL
using	NULL
the	NULL
indicated	NULL
antibodies	NULL
full-length	NULL
Ku70	NULL
and	NULL
only	NULL
the	NULL
variant	NULL
form	NULL
of	NULL
Ku86	NULL
(	NULL
see	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
the	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
heterodimer	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
DNA-PKg	NULL
.	NULL

Mechanism	NULL
(	NULL
s	NULL
)	NULL
that	NULL
contribute	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Ku86	NULL
variant	NULL
protein	NULL
To	NULL
test	NULL
if	NULL
the	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
arises	NULL
from	NULL
a	NULL
spliced	NULL
form	NULL
of	NULL
Ku86	NULL
,	NULL
Northern	NULL
blot	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
Ku86	NULL
cDNA	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
,	NULL
in	NULL
the	NULL
control	NULL
cell	NULL
line	NULL
AHH1	NULL
,	NULL
Ku86	NULL
probe	NULL
hybridized	NULL
to	NULL
two	NULL
mRNAs	NULL
of	NULL
2.6	NULL
and	NULL
3.4	NULL
kb	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Cai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Jongmans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
two	NULL
Ku86	NULL
transcripts	NULL
were	NULL
also	NULL
present	NULL
in	NULL
PBL	NULL
and	NULL
in	NULL
purified	NULL
B-lymphocytes	NULL
and	NULL
no	NULL
smaller	NULL
form	NULL
of	NULL
Ku86	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
B-lymphocytes	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
Ku	NULL
DNA-end	NULL
binding	NULL
activity	NULL
is	NULL
altered	NULL
in	NULL
peripheral	NULL
blood	NULL
B-lymphocytes	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
faster	NULL
mobility	NULL
complex	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
revealed	NULL
that	NULL
B	NULL
cells	NULL
express	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
69	NULL
kDa	NULL
,	NULL
and	NULL
not	NULL
the	NULL
86	NULL
kDa-	NULL
full-length	NULL
protein	NULL
.	NULL

Although	NULL
the	NULL
heterodimer	NULL
Ku70/variant-Ku86	NULL
binds	NULL
to	NULL
DNA-ends	NULL
,	NULL
this	NULL
altered	NULL
form	NULL
of	NULL
the	NULL
Ku	NULL
heterodimer	NULL
has	NULL
a	NULL
decreased	NULL
ability	NULL
to	NULL
recruit	NULL
the	NULL
catalytic	NULL
component	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
which	NULL
contributes	NULL
to	NULL
an	NULL
absence	NULL
of	NULL
detectable	NULL
DNA-PK	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Characteristics	NULL
of	NULL
the	NULL
variant	NULL
Ku86	NULL
protein	NULL
The	NULL
results	NULL
obtained	NULL
in	NULL
our	NULL
study	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
protein	NULL
detected	NULL
in	NULL
B-lymphocytes	NULL
indeed	NULL
corresponds	NULL
to	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
Ku8	NULL
#	NULL
6	NULL
rather	NULL
than	NULL
an	NULL
unrelated	NULL
protein	NULL
which	NULL
cross-reacts	NULL
with	NULL
Ku86	NULL
antibodies	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
active	NULL
DNA	NULL
end	NULL
binding	NULL
member	NULL
of	NULL
the	NULL
heterodimer	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
Ku70	NULL
(	NULL
Zhang	NULL
and	NULL
Yaneva	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

One	NULL
study	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
Ku70	NULL
might	NULL
carry	NULL
out	NULL
this	NULL
DEB	NULL
function	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ku86	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
but	NULL
this	NULL
remains	NULL
controversial	NULL
(	NULL
Griffith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
recent	NULL
work	NULL
using	NULL
in	NULL
vitro-translated	NULL
Ku	NULL
products	NULL
clearly	NULL
showed	NULL
that	NULL
full-length	NULL
individual	NULL
subunits	NULL
are	NULL
inactive	NULL
for	NULL
DEB	NULL
activity	NULL
indicating	NULL
that	NULL
heterodimer	NULL
assembly	NULL
precedes	NULL
,	NULL
and	NULL
is	NULL
necessary	NULL
for	NULL
PBL	NULL
LB	NULL
LB	NULL
Figure	NULL
7	NULL
Northern	NULL
blot	NULL
experiments	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
obtained	NULL
from	NULL
the	NULL
control	NULL
cell	NULL
line	NULL
AHHI1	NULL
(	NULL
H	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
or	NULL
B-lymphocytes	NULL
(	NULL
LB	NULL
,	NULL
two	NULL
independent	NULL
healthy	NULL
donors	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1.2	NULL
%	NULL
agarose	NULL
-	NULL
7	NULL
%	NULL
formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
Ku86	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
two	NULL
Ku86	NULL
mRNAs	NULL
transcripts	NULL
detected	NULL
is	NULL
indicated	NULL
3.4	NULL
kb	NULL
-	NULL
»	NULL
2.6	NULL
kb	NULL
-	NULL
»	NULL
Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
DNA-binding	NULL
(	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
since	NULL
Ku86	NULL
full-length	NULL
protein	NULL
is	NULL
undetectable	NULL
in	NULL
B-lymphocytes	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
second	NULL
band	NULL
detected	NULL
by	NULL
the	NULL
Western	NULL
blot	NULL
experiments	NULL
is	NULL
indeed	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
which	NULL
results	NULL
in	NULL
DEB	NULL
activity	NULL
by	NULL
the	NULL
assembly	NULL
with	NULL
Ku70	NULL
protein	NULL
.	NULL

Similar	NULL
expression	NULL
of	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
(	NULL
but	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
full-length	NULL
protein	NULL
)	NULL
has	NULL
been	NULL
recently	NULL
reported	NULL
in	NULL
the	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
HL60	NULL
(	NULL
Han	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
detected	NULL
in	NULL
B-lymphocytes	NULL
presents	NULL
similarities	NULL
with	NULL
the	NULL
protein	NULL
detected	NULL
in	NULL
HL60	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
both	NULL
studies	NULL
,	NULL
the	NULL
mAb	NULL
S10B1	NULL
(	NULL
aa	NULL
8-221	NULL
)	NULL
detected	NULL
a	NULL
doublet	NULL
consisting	NULL
of	NULL
two	NULL
lower	NULL
forms	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
with	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
69	NULL
and	NULL
71	NULL
kDa	NULL
.	NULL

In	NULL
the	NULL
HL60	NULL
cell	NULL
line	NULL
,	NULL
another	NULL
mAb	NULL
which	NULL
recognizes	NULL
the	NULL
610-705	NULL
aa	NULL
of	NULL
Ku86	NULL
(	NULL
mAb	NULL
111	NULL
)	NULL
failed	NULL
to	NULL
recognize	NULL
the	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
only	NULL
the	NULL
full-length	NULL
Ku86	NULL
was	NULL
detected	NULL
in	NULL
PBL	NULL
using	NULL
this	NULL
antibody	NULL
(	NULL
Ajmani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
mAb	NULL
111	NULL
also	NULL
fails	NULL
to	NULL
recognize	NULL
the	NULL
Ku86	NULL
variant	NULL
expressed	NULL
in	NULL
lymphocytes	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
mAb	NULL
150	NULL
which	NULL
recognizes	NULL
an	NULL
epitope	NULL
within	NULL
amino	NULL
acid	NULL
490	NULL
to	NULL
707	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
(	NULL
Kamiya	NULL
Biomedical	NULL
Co	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
,	NULL
USA	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
altered	NULL
Ku	NULL
heterodimer-DNA	NULL
complexes	NULL
in	NULL
EMSA	NULL
supershift	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
the	NULL
present	NULL
time	NULL
,	NULL
the	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
between	NULL
Ku86	NULL
or	NULL
the	NULL
Ku	NULL
heterodimer	NULL
with	NULL
the	NULL
catalytic	NULL
component	NULL
of	NULL
the	NULL
DNA-PKcs	NULL
complex	NULL
remain	NULL
(	NULL
s	NULL
)	NULL
unknown	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
the	NULL
mAb	NULL
111	NULL
(	NULL
aa	NULL
610-705	NULL
)	NULL
to	NULL
recognize	NULL
the	NULL
variant	NULL
form	NULL
of	NULL
Ku8	NULL
#	NULL
6	NULL
in	NULL
the	NULL
HL60	NULL
cell	NULL
line	NULL
(	NULL
Han	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
in	NULL
PBL	NULL
(	NULL
Ajmani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
of	NULL
the	NULL
mAb	NULL
150	NULL
(	NULL
aa	NULL
490-707	NULL
)	NULL
to	NULL
supershift	NULL
KuT7O0/variant	NULL
Ku8	NULL
#	NULL
6	NULL
DNA	NULL
complexes	NULL
(	NULL
our	NULL
results	NULL
)	NULL
may	NULL
implicate	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
this	NULL
function	NULL
.	NULL

However	NULL
,	NULL
only	NULL
reconstitution	NULL
studies	NULL
with	NULL
various	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
will	NULL
allow	NULL
this	NULL
question	NULL
to	NULL
be	NULL
answered	NULL
since	NULL
conformational	NULL
changes	NULL
induced	NULL
in	NULL
the	NULL
Ku86	NULL
variant	NULL
(	NULL
and	NULL
not	NULL
the	NULL
region	NULL
deleted	NULL
)	NULL
can	NULL
be	NULL
discounted	NULL
for	NULL
the	NULL
decreased	NULL
ability	NULL
to	NULL
recruit	NULL
DNA-PK	NULL
,	NULL
;	NULL
.	NULL

Presently	NULL
,	NULL
the	NULL
mechanism	NULL
which	NULL
contributes	NULL
to	NULL
the	NULL
expression	NULL
by	NULL
B	NULL
cells	NULL
of	NULL
this	NULL
variant	NULL
form	NULL
of	NULL
Ku86	NULL
remains	NULL
unknown	NULL
.	NULL

This	NULL
expression	NULL
appeared	NULL
however	NULL
to	NULL
result	NULL
from	NULL
a	NULL
significant	NULL
biological	NULL
event	NULL
occurring	NULL
within	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
a	NULL
nonspecific	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
Ku86	NULL
may	NULL
have	NULL
occurred	NULL
during	NULL
preparation	NULL
of	NULL
cell	NULL
extracts	NULL
can	NULL
be	NULL
ruled	NULL
out	NULL
since	NULL
,	NULL
(	NULL
i	NULL
)	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
variant	NULL
form	NULL
of	NULL
Ku86	NULL
was	NULL
observed	NULL
in	NULL
extracts	NULL
from	NULL
circulating	NULL
blood	NULL
lymphocytes	NULL
and	NULL
not	NULL
from	NULL
continuous	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
even	NULL
when	NULL
the	NULL
extract	NULL
preparations	NULL
were	NULL
performed	NULL
simultaneously	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
a	NULL
large	NULL
set	NULL
of	NULL
protease	NULL
inhibitors	NULL
was	NULL
used	NULL
during	NULL
protein	NULL
extraction	NULL
(	NULL
see	NULL
Material	NULL
and	NULL
methods	NULL
)	NULL
that	NULL
consistently	NULL
would	NULL
abrogate	NULL
the	NULL
cleavage	NULL
events	NULL
induced	NULL
by	NULL
the	NULL
major	NULL
classes	NULL
of	NULL
known	NULL
proteases	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
it	NULL
has	NULL
been	NULL
previously	NULL
demonstrated	NULL
that	NULL
unstimulated	NULL
B	NULL
cells	NULL
have	NULL
low	NULL
protease	NULL
activity	NULL
as	NULL
compared	NULL
to	NULL
mitogen-activated	NULL
cells	NULL
(	NULL
Kishi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
;	NULL
Ku	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
mechanism	NULL
that	NULL
contributes	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
variant	NULL
Ku86	NULL
protein	NULL
occurs	NULL
at	NULL
the	NULL
post-transcriptional	NULL
level	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
B-lymphocytes	NULL
express	NULL
the	NULL
two	NULL
Ku86	NULL
transcripts	NULL
also	NULL
detected	NULL
in	NULL
cell	NULL
lines	NULL
(	NULL
Cai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
1557	NULL
Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
1558	NULL
Jongmans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
and	NULL
our	NULL
present	NULL
results	NULL
)	NULL
,	NULL
and	NULL
not	NULL
a	NULL
smaller	NULL
form	NULL
,	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
variant	NULL
Ku86	NULL
protein	NULL
does	NULL
not	NULL
arise	NULL
from	NULL
a	NULL
spliced	NULL
form	NULL
of	NULL
Ku86	NULL
and	NULL
favor	NULL
the	NULL
involvement	NULL
of	NULL
event	NULL
such	NULL
as	NULL
specific	NULL
proteolysis	NULL
.	NULL

Implication	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
DNA-PK	NULL
activity	NULL
for	NULL
DNA	NULL
DSB	NULL
repair	NULL
activity	NULL
in	NULL
B	NULL
cell	NULL
lymphocytes	NULL
The	NULL
catalytic	NULL
component	NULL
of	NULL
the	NULL
DNA-PK	NULL
complex	NULL
is	NULL
essential	NULL
for	NULL
DNA	NULL
DSB	NULL
repair	NULL
activity	NULL
.	NULL

Indeed	NULL
,	NULL
mutant	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
the	NULL
hamster	NULL
V-3	NULL
and	NULL
the	NULL
murine	NULL
seid	NULL
cell	NULL
line	NULL
that	NULL
exhibited	NULL
normal	NULL
levels	NULL
of	NULL
Ku-DNA	NULL
ends	NULL
binding	NULL
activity	NULL
but	NULL
are	NULL
defective	NULL
in	NULL
the	NULL
catalytic	NULL
sub-unit	NULL
,	NULL
DNA-PKcs	NULL
(	NULL
Blunt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Peterson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
show	NULL
a	NULL
defect	NULL
in	NULL
DSB	NULL
repair	NULL
after	NULL
exposition	NULL
to	NULL
ionizing	NULL
radiation	NULL
.	NULL

Interestingly	NULL
,	NULL
among	NULL
normal	NULL
fresh	NULL
human	NULL
cells	NULL
,	NULL
resting	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
are	NULL
especially	NULL
sensitive	NULL
to	NULL
IR	NULL
and	NULL
within	NULL
sub-populations	NULL
of	NULL
lymphocytes	NULL
,	NULL
B	NULL
cells	NULL
are	NULL
more	NULL
sensitive	NULL
than	NULL
T	NULL
cells	NULL
(	NULL
Prosser	NULL
,	NULL
1976	NULL
;	NULL
Prusek	NULL
and	NULL
Astaldi	NULL
,	NULL
1979	NULL
;	NULL
Schwartz	NULL
and	NULL
Gaulden	NULL
,	NULL
1980	NULL
)	NULL
.	NULL

This	NULL
relative	NULL
radiosensitivity	NULL
appears	NULL
to	NULL
be	NULL
related	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
DNA-repair	NULL
capacity	NULL
of	NULL
these	NULL
cells	NULL
,	NULL
especially	NULL
in	NULL
the	NULL
rejoining	NULL
of	NULL
DSB	NULL
(	NULL
Mayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
major	NULL
functional	NULL
role	NULL
of	NULL
DNA-PK	NULL
in	NULL
DSBs	NULL
repair	NULL
,	NULL
the	NULL
observed	NULL
defect	NULL
in	NULL
DNA-PK	NULL
activity	NULL
in	NULL
our	NULL
study	NULL
provides	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
increased	NULL
sensitivity	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
ionizing	NULL
radiation	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
T	NULL
cells	NULL
,	NULL
on	NULL
the	NULL
contrary	NULL
,	NULL
appear	NULL
to	NULL
contain	NULL
detectable	NULL
levels	NULL
of	NULL
DNA-PK	NULL
activity	NULL
(	NULL
see	NULL
Figure	NULL
5	NULL
and	NULL
comments	NULL
)	NULL
,	NULL
our	NULL
data	NULL
may	NULL
explain	NULL
the	NULL
known	NULL
difference	NULL
in	NULL
sensitivity	NULL
towards	NULL
IR	NULL
between	NULL
these	NULL
two	NULL
lymphocyte	NULL
sub-populations	NULL
.	NULL

Besides	NULL
lymphocytes	NULL
,	NULL
differences	NULL
in	NULL
radiosensitivity	NULL
are	NULL
observed	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
different	NULL
tumor	NULL
types	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
normal	NULL
tissues	NULL
within	NULL
and	NULL
between	NULL
individuals	NULL
.	NULL

The	NULL
molecular	NULL
mechanism	NULL
responsible	NULL
for	NULL
these	NULL
differences	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
(	NULL
McMillan	NULL
and	NULL
Peacock	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
DNA-PK	NULL
activity	NULL
is	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
this	NULL
variation	NULL
in	NULL
radiosensitivity	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
for	NULL
normal	NULL
lymphocytes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
Ku86	NULL
variant	NULL
protein	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
vivo	NULL
and	NULL
studies	NULL
of	NULL
its	NULL
expression	NULL
and	NULL
distribution	NULL
amongst	NULL
primary	NULL
normal	NULL
human	NULL
cell	NULL
and	NULL
tissues	NULL
may	NULL
help	NULL
to	NULL
further	NULL
understand	NULL
the	NULL
physiological	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
underlying	NULL
the	NULL
relative	NULL
radiosensitivity	NULL
in	NULL
humans	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
Ku86	NULL
variant	NULL
in	NULL
B	NULL
cell	NULL
differentiation	NULL
Finally	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
DNA-PK	NULL
activity	NULL
is	NULL
regulated	NULL
during	NULL
B	NULL
cell	NULL
differentiation	NULL
in	NULL
a	NULL
stage	NULL
specific	NULL
manner	NULL
,	NULL
through	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
.	NULL

Indeed	NULL
,	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
occurs	NULL
at	NULL
defined	NULL
stages	NULL
of	NULL
lymphocyte	NULL
development	NULL
and	NULL
this	NULL
function	NULL
is	NULL
primarily	NULL
regulated	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
recombination	NULL
activating	NULL
genes	NULL
,	NULL
RAG1	NULL
and	NULL
RAG2	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Weaver	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Whether	NULL
or	NULL
not	NULL
the	NULL
expression	NULL
and	NULL
activity	NULL
of	NULL
DNA-PK	NULL
holoenzyme	NULL
is	NULL
also	NULL
actively	NULL
regulated	NULL
in	NULL
human	NULL
cells	NULL
upon	NULL
differentiation	NULL
and	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
rearrangement	NULL
still	NULL
remains	NULL
unknown	NULL
.	NULL

However	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
DNA-PK	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
process	NULL
suggests	NULL
that	NULL
this	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
actively	NULL
recombining	NULL
pro/pre-B	NULL
cells	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
absence	NULL
observed	NULL
in	NULL
our	NULL
study	NULL
in	NULL
unstimulated	NULL
circulating	NULL
B-lymphocytes	NULL
.	NULL

In	NULL
the	NULL
light	NULL
of	NULL
differences	NULL
in	NULL
DNA-PK	NULL
activity	NULL
between	NULL
circulating	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
observed	NULL
in	NULL
our	NULL
study	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
recently	NULL
published	NULL
works	NULL
underline	NULL
unsuspected	NULL
differences	NULL
in	NULL
the	NULL
molecular	NULL
regulation	NULL
of	NULL
early	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
differentiation	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
idea	NULL
that	NULL
partial	NULL
bypass	NULL
of	NULL
DNA-PK-dependent	NULL
pathway	NULL
of	NULL
DSBs	NULL
rejoining	NULL
may	NULL
occur	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
,	NULL
but	NULL
not	NULL
the	NULL
B	NULL
cell	NULL
,	NULL
lineage	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
single	NULL
treatment	NULL
of	NULL
newborn	NULL
seid	NULL
mice	NULL
with	NULL
DNA-damaging	NULL
agents	NULL
restored	NULL
functional	NULL
,	NULL
diverse	NULL
T	NULL
cell	NULL
receptor	NULL
B	NULL
chain	NULL
coding	NULL
joints	NULL
,	NULL
as	NULL
well	NULL
as	NULL
development	NULL
and	NULL
differentiation	NULL
of	NULL
thymocytes	NULL
,	NULL
but	NULL
did	NULL
not	NULL
promote	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
Danska	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
p53	NULL
deficiency	NULL
promoted	NULL
T	NULL
cell	NULL
development	NULL
but	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
circumvent	NULL
the	NULL
block	NULL
in	NULL
B	NULL
cell	NULL
maturation	NULL
conferred	NULL
by	NULL
the	NULL
scid	NULL
mutation	NULL
(	NULL
Guidos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Nacht	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

All	NULL
these	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
later	NULL
steps	NULL
involved	NULL
in	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
joining	NULL
are	NULL
not	NULL
regulated	NULL
identi-cally	NULL
,	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
whether	NULL
the	NULL
relative	NULL
expression	NULL
of	NULL
the	NULL
variant	NULL
form	NULL
of	NULL
Ku86	NULL
protein	NULL
is	NULL
used	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
to	NULL
actively	NULL
regulate	NULL
DNA-PK	NULL
activity	NULL
upon	NULL
differentiation	NULL
and	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
rearrangement	NULL
appears	NULL
an	NULL
important	NULL
issue	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
DNA-PK	NULL
activity	NULL
is	NULL
negatively	NULL
regulated	NULL
in	NULL
normal	NULL
circulating	NULL
B	NULL
cells	NULL
through	NULL
an	NULL
original	NULL
mechanism	NULL
that	NULL
involves	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variant	NULL
form	NULL
of	NULL
the	NULL
Ku86	NULL
protein	NULL
.	NULL

Whether	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
variant	NULL
protein	NULL
is	NULL
restricted	NULL
to	NULL
B	NULL
cells	NULL
amongst	NULL
primary	NULL
human	NULL
cells	NULL
and	NULL
tissues	NULL
,	NULL
and	NULL
the	NULL
molecular	NULL
mechanism	NULL
that	NULL
contributes	NULL
to	NULL
its	NULL
expression	NULL
,	NULL
appears	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
two	NULL
important	NULL
issues	NULL
that	NULL
are	NULL
currently	NULL
investigated	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Antibodies	NULL
Monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
KuS86	NULL
(	NULL
mAb	NULL
S10B1	NULL
,	NULL
Interchim	NULL
,	NULL
France	NULL
)	NULL
and	NULL
DNA-PK	NULL
;	NULL
(	NULL
mAb	NULL
18-2	NULL
,	NULL
provided	NULL
by	NULL
Dr	NULL
T	NULL
Carter	NULL
,	NULL
St-John	NULL
's	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
USA	NULL
)	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Carter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
Ku86	NULL
and	NULL
Ku70	NULL
(	NULL
designated	NULL
Ku86	NULL
pc	NULL
and	NULL
Ku70	NULL
pc	NULL
in	NULL
our	NULL
study	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Dr	NULL
Falaschi	NULL
(	NULL
UNIDO	NULL
,	NULL
Trieste	NULL
,	NULL
Italy	NULL
)	NULL
(	NULL
Tuteja	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
;	NULL
Human	NULL
serum	NULL
(	NULL
AF	NULL
)	NULL
that	NULL
contained	NULL
autoantibodies	NULL
that	NULL
cross-reacted	NULL
with	NULL
Ku70	NULL
and	NULL
Ku86	NULL
antigens	NULL
(	NULL
Francoeur	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Dr	NULL
EM	NULL
Tan	NULL
(	NULL
the	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
purified	NULL
antibodies	NULL
were	NULL
obtained	NULL
in	NULL
our	NULL
laboratory	NULL
by	NULL
the	NULL
protein	NULL
A	NULL
sepharose	NULL
procedure	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
and	NULL
transformed	NULL
cell	NULL
lines	NULL
Blood	NULL
samples	NULL
(	NULL
50	NULL
to	NULL
100	NULL
mL	NULL
)	NULL
were	NULL
collected	NULL
in	NULL
hepar-inized	NULL
tubes	NULL
from	NULL
healthy	NULL
consenting	NULL
volunteers	NULL
.	NULL

Mononuclear	NULL
cell	NULL
suspensions	NULL
were	NULL
obtained	NULL
after	NULL
Hypaque-Ficoll	NULL
(	NULL
MSL	NULL
,	NULL
Eurobio	NULL
,	NULL
France	NULL
)	NULL
gradient	NULL
centrifugation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Barret	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Mononuclear	NULL
cells	NULL
at	NULL
the	NULL
interface	NULL
were	NULL
collected	NULL
,	NULL
diluted	NULL
to	NULL
1	NULL
x	NULL
10°	NULL
cells/	NULL
ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
tissue	NULL
culture	NULL
flasks	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
to	NULL
remove	NULL
monocytes	NULL
by	NULL
adherence	NULL
.	NULL

After	NULL
monocyte	NULL
depletion	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
parts	NULL
.	NULL

The	NULL
first	NULL
part	NULL
of	NULL
the	NULL
sample	NULL
was	NULL
used	NULL
for	NULL
immediate	NULL
cell	NULL
extract	NULL
preparation	NULL
of	NULL
the	NULL
whole	NULL
lymphocyte	NULL
population	NULL
(	NULL
PBL	NULL
)	NULL
.	NULL

The	NULL
second	NULL
part	NULL
of	NULL
the	NULL
sample	NULL
was	NULL
processed	NULL
to	NULL
obtain	NULL
purified	NULL
B	NULL
cell	NULL
suspension	NULL
as	NULL
follows	NULL
:	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
antibody	NULL
to	NULL
CD3	NULL
(	NULL
mAb	NULL
UCHTI1	NULL
,	NULL
Dako	NULL
,	NULL
Trappes	NULL
,	NULL
France	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
then	NULL
removed	NULL
by	NULL
incubation	NULL
with	NULL
goat	NULL
anti-mouse	NULL
IgGl	NULL
(	NULL
Fc	NULL
)	NULL
antibody	NULL
coupled	NULL
to	NULL
magnetic	NULL
beads	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendation	NULL
(	NULL
Dynabeads	NULL
M-450	NULL
,	NULL
Dy-nal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
less	NULL
than	NULL
0.5	NULL
%	NULL
CD3	NULL
or	NULL
CD14	NULL
positive	NULL
cells	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
highly	NULL
purified	NULL
CD	NULL
19+	NULL
B	NULL
cell	NULL
population	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
>	NULL
90	NULL
%	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Following	NULL
purification	NULL
,	NULL
B-lymphocytes	NULL
were	NULL
immediately	NULL
used	NULL
for	NULL
cell	NULL
extract	NULL
preparation	NULL
or	NULL
RNA	NULL
extraction	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
immortalized	NULL
human	NULL
lymphoblastoid	NULL
AHH1	NULL
and	NULL
the	NULL
human	NULL
HeLa	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Cergy	NULL
Pontoise	NULL
,	NULL
France	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
125	NULL
U/ml	NULL
penicillin	NULL
,	NULL
and	NULL
125	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

Cell	NULL
extracts	NULL
Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
with	NULL
slight	NULL
modifications	NULL
(	NULL
Finnie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
extraction	NULL
buffer	NULL
(	NULL
2x	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
100	NULL
ul	NULL
for	NULL
transformed	NULL
cell	NULL
lines	NULL
and	NULL
5	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
100	NULL
ul	NULL
for	NULL
normal	NULL
human	NULL
lymphocytes	NULL
)	NULL
containing	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
450	NULL
mm	NULL
NaCl	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
proteinase	NULL
inhibitors	NULL
[	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluor-ide	NULL
,	NULL
0.5	NULL
ug/ml	NULL
apoprotin	NULL
,	NULL
0.5	NULL
ug/ml	NULL
chymostatin	NULL
,	NULL
0.5	NULL
ug/ml	NULL
leupeptin	NULL
and	NULL
1.5	NULL
ug/ml	NULL
pepstatin	NULL
]	NULL
,	NULL
then	NULL
frozen	NULL
on	NULL
dry	NULL
ice	NULL
and	NULL
thawed	NULL
at	NULL
30°C	NULL
three	NULL
times	NULL
.	NULL

After	NULL
centrifugation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
supernatants	NULL
were	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Band	NULL
shift	NULL
assay	NULL
The	NULL
probe	NULL
was	NULL
prepared	NULL
as	NULL
follows	NULL
:	NULL
an	NULL
aliquot	NULL
of	NULL
a	NULL
123-bp	NULL
DNA	NULL
ladder	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
France	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
Aval	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Cergy	NULL
Pontoise	NULL
,	NULL
France	NULL
)	NULL
in	NULL
order	NULL
to	NULL
generate	NULL
123	NULL
bp	NULL
monomers	NULL
.	NULL

After	NULL
purification	NULL
from	NULL
agarose	NULL
gel	NULL
,	NULL
fragments	NULL
were	NULL
end-labeled	NULL
with	NULL
«	NULL
-	NULL
``	NULL
P-dCTP	NULL
using	NULL
DNA	NULL
polymerase	NULL
I	NULL
Klenow	NULL
fragment	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
France	NULL
)	NULL
.	NULL

End-labeled	NULL
probes	NULL
were	NULL
separated	NULL
from	NULL
unincorporated	NULL
nucleotides	NULL
by	NULL
chromatography	NULL
through	NULL
Sephadex	NULL
G-50	NULL
(	NULL
Sigma	NULL
,	NULL
Saint	NULL
Quentin	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
band	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Zhang	NULL
and	NULL
Yaneva	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
the	NULL
supershift	NULL
experiments	NULL
,	NULL
antibodies	NULL
(	NULL
at	NULL
the	NULL
indicated	NULL
concentration	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
following	NULL
10	NULL
min	NULL
incubation	NULL
at	NULL
30°C	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
prior	NULL
to	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Western	NULL
blot	NULL
Proteins	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
electroblotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
using	NULL
a	NULL
semi-dry	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
Trans-Blot	NULL
,	NULL
Bio-Rad	NULL
,	NULL
Ivry-	NULL
References	NULL
Ajmani	NULL
AK	NULL
,	NULL
Satoh	NULL
M	NULL
,	NULL
Reap	NULL
E	NULL
,	NULL
Cohen	NULL
PL	NULL
and	NULL
Reeves	NULL
WH	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
2049-2058	NULL
.	NULL

Anderson	NULL
CW	NULL
,	NULL
Connelly	NULL
MA	NULL
,	NULL
Zhang	NULL
H	NULL
,	NULL
Sipley	NULL
JD	NULL
,	NULL
Leesmiller	NULL
SP	NULL
,	NULL
Sakaguchi	NULL
K	NULL
,	NULL
Ullrich	NULL
SJ	NULL
,	NULL
Jackson	NULL
SP	NULL
and	NULL
Appella	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Protein	NULL
Chem	NULL
.	NULL

,	NULL
13	NULL
,	NULL
500-501	NULL
.	NULL

Barret	NULL
JM	NULL
,	NULL
Calsou	NULL
P	NULL
and	NULL
Salles	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Carcinogenesis	NULL
,	NULL
7	NULL
,	NULL
1611-1616	NULL
.	NULL

Biedermann	NULL
KA	NULL
,	NULL
San	NULL
JR	NULL
,	NULL
Giaccia	NULL
AJ	NULL
,	NULL
Tosto	NULL
LM	NULL
and	NULL
Brown	NULL
JM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
1394-1397	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
sur-Seine	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Muller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Antibodies	NULL
used	NULL
in	NULL
Western-blotting	NULL
experiments	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
the	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
Ku70	NULL
and	NULL
Ku80	NULL
proteins	NULL
were	NULL
used	NULL
at	NULL
a	NULL
1:2500	NULL
dilution	NULL
(	NULL
secondary	NULL
antibody	NULL
mouse	NULL
anti-rabbit	NULL
at	NULL
a	NULL
1:2500	NULL
dilution	NULL
)	NULL
.	NULL

The	NULL
purified	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
Ku86	NULL
(	NULL
mAb	NULL
S10B1	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
1	NULL
:	NULL
1000	NULL
dilution	NULL
and	NULL
the	NULL
anti	NULL
DNA-PKcs	NULL
antibody	NULL
18-2	NULL
at	NULL
a	NULL
1:5000	NULL
dilution	NULL
(	NULL
secondary	NULL
antibody	NULL
goat	NULL
anti-mouse	NULL
at	NULL
a	NULL
1:2500	NULL
and	NULL
1	NULL
:	NULL
5000	NULL
dilution	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

DNA-PK	NULL
assay	NULL
DNA-PK	NULL
'pulldown	NULL
'	NULL
kinase	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Finnie	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
certain	NULL
experiments	NULL
,	NULL
after	NULL
incubation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
double-stranded	NULL
DNA-cellulose	NULL
beads	NULL
(	NULL
Sigma	NULL
,	NULL
Saint-Quentin	NULL
,	NULL
France	NULL
)	NULL
,	NULL
beads	NULL
were	NULL
extensively	NULL
washed	NULL
with	NULL
Z	NULL
'	NULL
0.05	NULL
buffer	NULL
[	NULL
25	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
10	NULL
mw	NULL
MgC12	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
%	NULL
Nodinet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
dithio-threitol	NULL
]	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
50	NULL
mm	NULL
Tris-HCI	NULL
pH	NULL
9.0/	NULL
Triton	NULL
1	NULL
%	NULL
with	NULL
constant	NULL
agitation	NULL
to	NULL
elute	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
beads	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
electrophoresed	NULL
in	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
filters	NULL
which	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
DNA-PKcs	NULL
,	NULL
and	NULL
Ku	NULL
proteins	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

Northern	NULL
blotting	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
lymphocytes	NULL
and	NULL
control	NULL
cell	NULL
line	NULL
(	NULL
AHH1	NULL
)	NULL
using	NULL
TRIZOL	NULL
reagent	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendation	NULL
.	NULL

Five	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
RNA	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
a	NULL
1.2	NULL
%	NULL
agarose	NULL
7	NULL
%	NULL
formaldehyde	NULL
gel	NULL
.	NULL

RNA	NULL
was	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
hybridized	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Muller	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
using	NULL
a	NULL
Ku86	NULL
cDNA	NULL
probe	NULL
(	NULL
from	NULL
nucleotide	NULL
248	NULL
to	NULL
nucleotide	NULL
1198	NULL
)	NULL
.	NULL

Before	NULL
hybridization	NULL
experiments	NULL
the	NULL
transfer	NULL
membranes	NULL
were	NULL
photographed	NULL
under	NULL
U.V	NULL
.	NULL

light	NULL
to	NULL
assess	NULL
the	NULL
amount	NULL
of	NULL
rRNA	NULL
by	NULL
ethidium	NULL
bromide	NULL
fluorescence	NULL
.	NULL

Acknowledgements	NULL
The	NULL
excellent	NULL
technical	NULL
assistance	NULL
by	NULL
Helene	NULL
Vinial	NULL
is	NULL
gratefully	NULL
acknowledged	NULL
.	NULL

We	NULL
thank	NULL
Dr	NULL
Defais	NULL
,	NULL
Dr	NULL
Jonhson	NULL
(	NULL
IPBS	NULL
,	NULL
Toulouse	NULL
,	NULL
France	NULL
)	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Dr	NULL
EM	NULL
Tan	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
the	NULL
AF	NULL
serum	NULL
,	NULL
to	NULL
Dr	NULL
T	NULL
Carter	NULL
and	NULL
Dr	NULL
A	NULL
Falaschi	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
the	NULL
antibodies	NULL
directed	NULL
against	NULL
and	NULL
Ku	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
'Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
'	NULL
,	NULL
the	NULL
'Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
'	NULL
and	NULL
the	NULL
'Fondation	NULL
de	NULL
France	NULL
'	NULL
.	NULL

CM	NULL
is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
post-doctoral	NULL
fellowship	NULL
from	NULL
the	NULL
'Comité	NULL
leucémie	NULL
de	NULL
la	NULL
Fondation	NULL
de	NULL
France	NULL
'	NULL
.	NULL

Blier	NULL
PR	NULL
,	NULL
Griffith	NULL
AJ	NULL
,	NULL
Craft	NULL
J	NULL
and	NULL
Hardin	NULL
JA	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
7594-7601	NULL
.	NULL

Blunt	NULL
T	NULL
,	NULL
Gell	NULL
D	NULL
,	NULL
Fox	NULL
M	NULL
,	NULL
Taccioli	NULL
GE	NULL
,	NULL
Lehmann	NULL
AR	NULL
,	NULL
Jackson	NULL
SP	NULL
and	NULL
Jeggo	NULL
PA.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
,	NULL
10285-10290	NULL
.	NULL

Blunt	NULL
T	NULL
,	NULL
Finnie	NULL
NJ	NULL
,	NULL
Taccioli	NULL
GE	NULL
,	NULL
Smith	NULL
GC	NULL
,	NULL
Demengeot	NULL
J	NULL
,	NULL
Gottlieb	NULL
TM	NULL
,	NULL
Mizuta	NULL
R	NULL
,	NULL
Varghese	NULL
AJ	NULL
,	NULL
Alt	NULL
FW	NULL
,	NULL
Jeggo	NULL
PA	NULL
and	NULL
Jackson	NULL
SP	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
,	NULL
813-823	NULL
.	NULL

1559	NULL
Negative	NULL
regulation	NULL
of	NULL
DNA-PK	NULL
activity	NULL
in	NULL
normal	NULL
B-lymphocytes	NULL
C	NULL
Muller	NULL
et	NULL
al	NULL
1560	NULL
Cai	NULL
QQ	NULL
,	NULL
Plet	NULL
AA	NULL
,	NULL
Imbert	NULL
J	NULL
,	NULL
Lafagepochitaloff	NULL
M	NULL
,	NULL
Cerdan	NULL
C	NULL
and	NULL
Blanchard	NULL
JM	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Cytogen	NULL
.	NULL

Cell	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
65	NULL
,	NULL
221	NULL
227	NULL
.	NULL

Cao	NULL
QP	NULL
,	NULL
Pitt	NULL
S	NULL
,	NULL
Leszyk	NULL
J	NULL
and	NULL
Baril	NULL
EF	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Biochemistry	NULL
,	NULL
33	NULL
,	NULL
8548-8557	NULL
.	NULL

Carter	NULL
T	NULL
,	NULL
Vancurova	NULL
I	NULL
,	NULL
Sun	NULL
I	NULL
,	NULL
Lou	NULL
W	NULL
and	NULL
DeLeon	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
6460-6471	NULL
.	NULL

Danska	NULL
JS	NULL
,	NULL
Holland	NULL
DP	NULL
,	NULL
Mariathasan	NULL
S	NULL
,	NULL
Williams	NULL
KM	NULL
and	NULL
Guidos	NULL
CJ	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
5507-5517	NULL
.	NULL

Danska	NULL
JS	NULL
,	NULL
Pflumio	NULL
F	NULL
,	NULL
Williams	NULL
CJ	NULL
,	NULL
Huner	NULL
O	NULL
,	NULL
Dick	NULL
JE	NULL
,	NULL
Guidos	NULL
CJ	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
266	NULL
,	NULL
450-455.	NULL
deVries	NULL
E	NULL
,	NULL
van	NULL
Driel	NULL
W	NULL
,	NULL
Bergsma	NULL
WG	NULL
,	NULL
Arnberg	NULL
AC	NULL
and	NULL
Van	NULL
der	NULL
Vliet	NULL
PC	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
208	NULL
,	NULL
65-78	NULL
.	NULL

Falzon	NULL
M	NULL
,	NULL
Fewell	NULL
JW	NULL
and	NULL
Kuff	NULL
EL	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
10546-10552	NULL
.	NULL

Finnie	NULL
NJ	NULL
,	NULL
Gottlieb	NULL
TM	NULL
,	NULL
Blunt	NULL
T	NULL
,	NULL
Jeggo	NULL
PA	NULL
and	NULL
Jackson	NULL
SP	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
320-324	NULL
.	NULL

Finnie	NULL
NJ	NULL
,	NULL
Gottlieb	NULL
TM	NULL
,	NULL
Blunt	NULL
T	NULL
,	NULL
Jeggo	NULL
PA	NULL
and	NULL
Jackson	NULL
SP	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Phil	NULL
.	NULL

Trans	NULL
.	NULL

Royal	NULL
Soc	NULL
.	NULL

,	NULL
351	NULL
,	NULL
173-179	NULL
.	NULL

Francoeur	NULL
AM	NULL
,	NULL
Peebles	NULL
CL	NULL
,	NULL
Gompper	NULL
PT	NULL
and	NULL
Tan	NULL
EM	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
136	NULL
,	NULL
1648-1653	NULL
.	NULL

Giffin	NULL
W	NULL
,	NULL
Torrance	NULL
H	NULL
,	NULL
Rodda	NULL
DJ	NULL
,	NULL
Prefontaine	NULL
GG	NULL
,	NULL
Pope	NULL
L	NULL
and	NULL
Hache	NULL
RJG	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
380	NULL
,	NULL
265-268	NULL
.	NULL

Gottlieb	NULL
TM	NULL
and	NULL
Jackson	NULL
SP	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
72	NULL
,	NULL
131-142	NULL
.	NULL

Griffith	NULL
AJ	NULL
,	NULL
Blier	NULL
PR	NULL
,	NULL
Minori	NULL
T	NULL
and	NULL
Hardin	NULL
JA	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
267	NULL
,	NULL
331-338	NULL
.	NULL

Guidos	NULL
CJ	NULL
,	NULL
Williams	NULL
CJ	NULL
,	NULL
Grandal	NULL
I	NULL
,	NULL
Knowles	NULL
G	NULL
,	NULL
Huang	NULL
MT	NULL
and	NULL
Danska	NULL
JS	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
1054-1072	NULL
.	NULL

Han	NULL
Z	NULL
,	NULL
Johnston	NULL
C	NULL
,	NULL
Reeves	NULL
WH	NULL
,	NULL
Carter	NULL
T	NULL
,	NULL
Wyche	NULL
JH	NULL
and	NULL
Hendrickson	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
14098-14104	NULL
.	NULL

Hartley	NULL
KO	NULL
,	NULL
Gell	NULL
D	NULL
,	NULL
Smith	NULL
GC	NULL
,	NULL
Zhang	NULL
H	NULL
,	NULL
Divecha	NULL
N	NULL
,	NULL
Connelly	NULL
MA	NULL
,	NULL
Admon	NULL
A	NULL
,	NULL
Leesmiller	NULL
SP	NULL
,	NULL
Anderson	NULL
CW	NULL
and	NULL
Jackson	NULL
SP	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
82	NULL
,	NULL
849-856	NULL
.	NULL

Henderickson	NULL
EA	NULL
,	NULL
Qin	NULL
XQ	NULL
,	NULL
Bump	NULL
EA	NULL
,	NULL
Schatz	NULL
DG	NULL
,	NULL
Oettinger	NULL
M	NULL
and	NULL
Weaver	NULL
DT	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
4061-4065	NULL
.	NULL

Jeggo	NULL
PA.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Mutation	NULL
Res	NULL
.	NULL

,	NULL
384	NULL
,	NULL
1-14	NULL
.	NULL

Jongmans	NULL
W	NULL
,	NULL
Artuso	NULL
M	NULL
,	NULL
Vuillaume	NULL
M	NULL
,	NULL
Brésil	NULL
H	NULL
,	NULL
Jackson	NULL
SP	NULL
and	NULL
Hall	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
13	NULL
,	NULL
1133-1138	NULL
.	NULL

Kishi	NULL
H	NULL
,	NULL
Miki	NULL
Y	NULL
,	NULL
Kikutani	NULL
H	NULL
,	NULL
Yamamura	NULL
Y	NULL
and	NULL
Kishimoto	NULL
T.	NULL
(	NULL
1983	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
131	NULL
,	NULL
1961-1965	NULL
.	NULL

Ku	NULL
GS	NULL
,	NULL
Quigley	NULL
JP	NULL
and	NULL
Sultzer	NULL
BM	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
131	NULL
,	NULL
2444-2449	NULL
.	NULL

Mayer	NULL
PJ	NULL
,	NULL
Bradley	NULL
MO	NULL
and	NULL
Nichols	NULL
WW	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

Mutation	NULL
Res	NULL
.	NULL

,	NULL
166	NULL
,	NULL
275-285	NULL
.	NULL

McMillan	NULL
TJ	NULL
and	NULL
Peacock	NULL
JH	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Radiat	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
49-55	NULL
.	NULL

Minori	NULL
T	NULL
and	NULL
Hardin	NULL
JA	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
261	NULL
,	NULL
10375	NULL
10379	NULL
.	NULL

Minori	NULL
T	NULL
,	NULL
Akizuki	NULL
M	NULL
,	NULL
Yamagata	NULL
H	NULL
,	NULL
Inada	NULL
S	NULL
,	NULL
Yoshida	NULL
S	NULL
and	NULL
Homma	NULL
M.	NULL
(	NULL
1981	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
68	NULL
,	NULL
611-620	NULL
.	NULL

Muller	NULL
C	NULL
,	NULL
Bailly	NULL
JD	NULL
,	NULL
Goubin	NULL
F	NULL
,	NULL
Laredo	NULL
J	NULL
,	NULL
Jaffrezou	NULL
JP	NULL
,	NULL
Bordier	NULL
C	NULL
and	NULL
Laurent	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
56	NULL
,	NULL
749	NULL
754	NULL
.	NULL

Nacht	NULL
M	NULL
,	NULL
Strasser	NULL
A	NULL
,	NULL
Chan	NULL
YR	NULL
,	NULL
Harris	NULL
AW	NULL
,	NULL
Schlissel	NULL
M	NULL
,	NULL
Bronson	NULL
RT	NULL
and	NULL
Jacks	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Gene	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
2055-2066	NULL
.	NULL

Peterson	NULL
SR	NULL
,	NULL
Kurimasa	NULL
A	NULL
,	NULL
Oshimura	NULL
M	NULL
,	NULL
Dynan	NULL
WS	NULL
,	NULL
Bradbury	NULL
EM	NULL
and	NULL
Chen	NULL
DJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
3171-3174	NULL
.	NULL

Prosser	NULL
JS	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Radiat	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
30	NULL
,	NULL
459-465	NULL
.	NULL

Prusek	NULL
W	NULL
and	NULL
Astaldi	NULL
G.	NULL
(	NULL
1979	NULL
)	NULL
.	NULL

Arch	NULL
.	NULL

Immunol	NULL
.	NULL

Ther	NULL
.	NULL

Exp	NULL
.	NULL

,	NULL
27	NULL
,	NULL
59-71	NULL
.	NULL

Schuller	NULL
W	NULL
,	NULL
Weiler	NULL
IJ	NULL
,	NULL
Schuller	NULL
A	NULL
,	NULL
Phillips	NULL
RA	NULL
,	NULL
Rosenberg	NULL
N	NULL
,	NULL
Mak	NULL
TW	NULL
,	NULL
Kearney	NULL
JF	NULL
,	NULL
Perry	NULL
RP	NULL
and	NULL
Bosma	NULL
MJ	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
46	NULL
,	NULL
963-972	NULL
.	NULL

Schwartz	NULL
JL	NULL
and	NULL
Gaulden	NULL
ME	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
.	NULL

Environ	NULL
.	NULL

Mutagen	NULL
.	NULL

,	NULL
2	NULL
,	NULL
473-485	NULL
.	NULL

Tutegja	NULL
N	NULL
,	NULL
Tuteja	NULL
R	NULL
,	NULL
Ochem	NULL
A	NULL
,	NULL
Tangja	NULL
P	NULL
,	NULL
Huang	NULL
NW	NULL
,	NULL
Simonecsits	NULL
A	NULL
,	NULL
Susic	NULL
S	NULL
,	NULL
Rahman	NULL
K	NULL
,	NULL
Marusic	NULL
L	NULL
,	NULL
Chen	NULL
J	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Ponger	NULL
S	NULL
and	NULL
Falaschi	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
4991-5001	NULL
.	NULL

Wang	NULL
J	NULL
,	NULL
Chou	NULL
CH	NULL
,	NULL
Blankson	NULL
J	NULL
,	NULL
Satoh	NULL
M	NULL
,	NULL
Knuth	NULL
MW	NULL
,	NULL
Eisenberg	NULL
RA	NULL
,	NULL
Pisetsky	NULL
DS	NULL
and	NULL
Reeves	NULL
WH	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Rep.	NULL
,	NULL
18	NULL
,	NULL
15-28	NULL
.	NULL

Wang	NULL
J	NULL
,	NULL
Satoh	NULL
M	NULL
,	NULL
Chou	NULL
CH	NULL
and	NULL
Reeves	NULL
WH	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

,	NULL
351	NULL
,	NULL
219-224	NULL
.	NULL

Weaver	NULL
DT	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
58	NULL
,	NULL
29-84	NULL
.	NULL

Wu	NULL
X	NULL
and	NULL
Lieber	NULL
MR.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
5186-5193	NULL
.	NULL

Yaneva	NULL
M	NULL
and	NULL
Jhiang	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1090	NULL
,	NULL
181-187	NULL
.	NULL

Zhang	NULL
WW	NULL
and	NULL
Yaneva	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

,	NULL
186	NULL
,	NULL
574-579	NULL
.	NULL

Zhu	NULL
C	NULL
,	NULL
Bogue	NULL
MA	NULL
,	NULL
Lim	NULL
DS	NULL
,	NULL
Hasty	NULL
P	NULL
and	NULL
Roth	NULL
DB	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
86	NULL
,	NULL
379-389	NULL
.	NULL

